Vietnam’s Imexpharm Loans Millions For COVID-19 Response
Financing Agreement With ABD Will Ensure Supply
Vietnamese firm Imexpharm has received $8m in financing from the Asian Development Bank to help sustain local production considering the novel coronavirus pandemic.
You may also be interested in...
Novartis has expanded its efforts to help low- and lower-middle-income countries “mitigate the impact of the pandemic and support healthcare systems,” after signing a memorandum of understanding with Vietnam’s Ministry of Health providing various treatments for COVID-19 at-cost.
Viatris remains committed to completing the sale of its global biosimilars unit to Biocon Biologics, while continuing efforts to generate up to $9bn in pre-tax proceeds by the end of 2023 from divestments.
Viatris is committing to earlier EBITDA and free cash flow targets for 2022, although it now expects to lose a chunk of revenues for the full year amid severe and sustained foreign currency exposure.